Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment
Oncology Research and Treatment · 2019 · 42 (9) · 458-465
DOI: 10.1159/000501129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research and Treatment, online erschienen am 10.07.2019. Verfasst von Katsiaryna Laryionava und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany. Hauptthemen laut MEDLINE: Communication, Longevity, Physician-Patient Relations, Quality of Life. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Cancer patients often face decisions whether to proceed with cancer-specific treatment or to switch to best supportive care. In these decisions, patients’ preferences should be determining cornerstones. The aim of this survey was to elicit patients’ preferences regarding discussions about forgoing treatment and factors influencing their preferences.
Methods
We surveyed 194 patients at the National Center for Tumor Diseases, Germany. Quality of life (FACT-G), cancer-specific distress (QSC-R10), anxiety/depression (PHQ-4/GAD-2), preferences regarding quality/length of life (QQ), patient-physician communication (CARES-SF), and family role (CCAT-P) were assessed.
Results
Patients weighting quality of life over lifetime wanted their oncologists to address treatment limitations as early as possible (p = 0.00). Patients striving for a longer lifetime did not want such discussions (p = 0.05). Having discussed treatment limitations was not associated with increased anxiety, depression, or distress. Limiting treatment was discussed only with one-third of the patients with a prognosis of less than 6 months and rather with elderly patients or patients in a worse medical condition. Attributing an important role to family decisions was associated with striving for lifetime (p = 0.01).
Conclusion
Preferences for either quality or length of life were associated with patients’ willingness to discuss forgoing cancer-specific treatment. Timely discussion of realistic treatment goals is one way to avoid overtreatment. Patients striving for lifetime require increased attention and opportunities to address prognosis and risks of treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
- Program for Ethics and Patient-Oriented Care in Oncology, Heidelberg University Hospital, Heidelberg, Germany.
- Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.
- Hospital for Forensic Psychiatry, District Hospital Ansbach, Ansbach, Germany.
- Oncological Center Oberland, Department of Psycho-Oncology, Hospital Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany.
- Department of Thoracic Oncology, University Hospital Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany.
Zitieren
APA
Laryionava, K., Hartmann, M., Sklenarova, H., Heussner, P., Villalobos, M., Jäger, D., & Winkler, E. C. (2019). Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment. Oncology Research and Treatment, 42(9), 458-465. https://doi.org/10.1159/000501129
Vancouver
Laryionava K, Hartmann M, Sklenarova H, Heussner P, Villalobos M, Jäger D, et al. Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment. Oncology Research and Treatment. 2019;42(9):458-465. doi:10.1159/000501129
BibTeX
@article{Laryionava2019,
author = {Laryionava, Katsiaryna and Hartmann, Mechthild and Sklenarova, Halina and Heussner, Pia and Villalobos, Matthias and Jäger, Dirk and Winkler, Eva C},
title = {Cancer Patients’ Preferences for either Quality of Life or a Longer Life Determine Their Willingness to Talk about Forgoing Cancer-Specific Treatment},
journal = {Oncology Research and Treatment},
year = {2019},
volume = {42},
number = {9},
pages = {458--465},
doi = {10.1159/000501129}
}
EUVIMED